Factors Related to Small- and Mid-Capitalization Pharmaceutical Company Success Using Stock Performance as a Surrogate

Background Developing novel pharmaceuticals demands substantial investment despite high uncertainty of success and ultimate market value. While many established drug companies are highly profitable and have large portfolios of diversified assets, much of new drug innovation, a very high-risk, high-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferris, Matthew J, Sun, Kai, Savard, Corey, Suresh, Tejas, Mishra, Mark V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526070/
https://www.ncbi.nlm.nih.gov/pubmed/34692353
http://dx.doi.org/10.7759/cureus.18210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526070/
https://www.ncbi.nlm.nih.gov/pubmed/34692353
http://dx.doi.org/10.7759/cureus.18210

Ejemplares similares